Genprex Inc (GNPX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.56M
Last updated: Nov 17, 2026 at 4:39 PM ET
Genprex Inc (GNPX) Statistics
Genprex (GNPX) has a market cap of $1.56M. It holds $15.35M more cash than debt, 985.44% of its market cap.
Total Valuation
| Market Cap | $1.56M |
|---|---|
| Latest price (Nov 17, 2026) | $1.90 |
Key Dates
The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 29, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 13, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 97.91% over 52 weeks and trades 27.48% below its 50-day average.
| Beta (1Y) | 0.76 |
|---|---|
| 52-Week Change | -97.91% |
| 1-Month Change | -9.95% |
| 3-Month Change | -51.90% |
| 6-Month Change | -89.27% |
| 5-Year Change | -100.00% |
| Total Return (1Y) | -97.91% |
| Total Return (3Y CAGR) | -94.42% |
| Total Return (5Y CAGR) | -87.88% |
| Return vs SPY (1Y) | -109.22% |
| Max Drawdown (1Y) | -98.14% |
| Max Drawdown (3Y) | -99.99% |
| Sharpe Ratio (1Y) | -3.57 |
| Correlation with SPY (1Y) | 0.10 |
| 50-Day Average | $2.62 |
| 200-Day Average | $17.26 |
| 52-Week Range | $1.71 to $85.14 |
| RSI (14 Days) | 35.6 |
| Average Volume (20 Days) | 153.16K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 4.26x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 4.26x |
|---|---|
| Quick Ratio | 4.26x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -123.40% and return on assets is -96.66% over the last 12 months.
| Return on Equity (ROE) | -123.40% |
|---|---|
| Return on Assets (ROA) | -96.66% |
| Return on Capital Employed (ROCE) | -124.24% |
Scores
GNPX has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$16.77M |
| Pretax Income | -$17.07M |
| Net Income | -$16.94M |
| EBIT | -$17.05M |
| Reported EPS (TTM) | -$54.15 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 78.31% of the $17.52M in total assets.
| Cash and Equivalents | $15.35M |
|---|---|
| Total Debt | $0 |
| Net Cash | $15.35M |
| Net Cash Per Share | $19.19 |
| Working Capital | $12.39M |
| Shareholder Equity | $13.72M |
| Book Value Per Share | $17.16 |
| Total Assets | $17.52M |
| Total Liabilities | $3.80M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$15.31M |
|---|---|
| FCF Per Share | -$18.68 |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
GNPX does not pay a dividend.
| Buyback Yield | -1941.74% |
|---|---|
| Shareholder Yield | -1941.74% |
Stock Splits
The last split was a 1-for-22 reverse split on Jul 16, 2026.
| Last Split Date | Jul 16, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:22 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About GNPX
What is GNPX's market cap?
Genprex has a market cap of $1.56M.
How many shares of GNPX are outstanding?
Genprex has 799.62K shares outstanding.
Does GNPX pay a dividend?
No. Genprex does not pay a dividend.
How much debt does GNPX have?
Genprex has $0 of total debt and $15.35M of cash and equivalents, a net cash position of $15.35M.
GNPX pages: Overview, Charting, Earnings, Financials, Statistics, Competitors